Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study/Experiment 1
From BugSigDB
Reviewed Marked as Reviewed by Atrayees on 2023-6-29
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Neuromyelitis optica Devic disease,Devic syndrome,Devic's disease,Devic's neuromyelitis optica,Devic's syndrome,neuromyelitis optica,NMO,Neuromyelitis optica
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- healthy controls
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- neuromyelitis optica spectrum disorder
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Each patient met the 2015 international diagnostic criteria for NMOSD and tested positive for serum AQP4-IgG using cell-based assays
- Group 0 sample size Number of subjects in the control (unexposed) group
- 20
- Group 1 sample size Number of subjects in the case (exposed) group
- 20
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- currently taking antibiotics
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Statistical test
- LEfSe
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 3
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
- Richness Number of species
- unchanged
Signature 1
Reviewed Marked as Reviewed by Atrayees on 2023-6-29
Source: Figure 3
Description: Abundance of gut microbiota between the NMOSD and HS groups
Abundance in Group 1: increased abundance in neuromyelitis optica spectrum disorder
Revision editor(s): WikiWorks
Signature 2
Reviewed Marked as Reviewed by Atrayees on 2023-6-29
Source: Figure 3, text
Description: Abundance of gut microbiota between the NMOSD and HS groups
Abundance in Group 1: decreased abundance in neuromyelitis optica spectrum disorder
| NCBI | Quality Control | Links |
|---|---|---|
| Sutterella | ||
| Fusicatenibacter | ||
| Coprococcus | ||
| Peptostreptococcaceae | ||
| Romboutsia | ||
| Blautia | ||
| Roseburia | ||
| Lachnospiraceae | ||
| Faecalibacterium | ||
| Prevotellaceae | ||
| Eubacteriales | ||
| Clostridia | ||
| Prevotella |
